Howe & Rusling’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-15
Closed -$3K 633
2022
Q3
$3K Buy
15
+1
+7% +$199 ﹤0.01% 784
2022
Q2
$2K Buy
14
+1
+8% +$215 ﹤0.01% 866
2022
Q1
$3K Sell
13
-50
-79% -$12.6K ﹤0.01% 781
2021
Q4
$16K Hold
63
﹤0.01% 464
2021
Q3
$15K Hold
63
﹤0.01% 452
2021
Q2
$13K Sell
63
-2
-3% -$408 ﹤0.01% 458
2021
Q1
$12K Buy
65
+54
+491% +$9.52K ﹤0.01% 468
2020
Q4
$2K Hold
11
﹤0.01% 802
2020
Q3
$1K Hold
11
﹤0.01% 774
2020
Q2
$1K Buy
+11
New +$1.14K ﹤0.01% 744
2018
Q1
Sell
-500
Closed -$44K 963
2017
Q4
$44K Hold
500
0.01% 307
2017
Q3
$40K Hold
500
0.01% 322
2017
Q2
$44K Hold
500
0.01% 278
2017
Q1
$44K Hold
500
0.01% 269
2016
Q4
$37K Buy
+500
New +$37.4K 0.01% 297

Other funds holding HCA

Howe & Rusling's HCA Position: Q4 2022 in Review

Howe & Rusling sold out of HCA Healthcare (HCA) in Q4 2022, closing a stake of 15 shares — an estimated $3K sold.

Howe & Rusling first reported a position in HCA in Q4 2016 and held it in 15 quarters. The position peaked at $44K in Q4 2017. 960 funds tracked by Wall St. Rank hold HCA as of Q4 2022.

  • Howe & Rusling reported no remaining HCA Healthcare position as of Q4 2022 after selling out during the quarter.
  • Howe & Rusling sold 15 HCA Healthcare shares in Q4 2022, an estimated $3K.
  • Howe & Rusling first reported a position in HCA Healthcare in Q4 2016 and held it in 15 quarters.
  • Howe & Rusling's HCA Healthcare position peaked at $44K in Q4 2017.
  • 960 funds tracked by Wall St. Rank held HCA Healthcare as of Q4 2022.

Based on Howe & Rusling's 13F filing for Q4 2022, filed 15 Feb 2023.